NVN Liquidation, Inc. (0A4P.L)

0.0008 0.0000 (0.00%) At close: 06:31PM BST

NVN Liquidation, Inc.

4020 Stirrup Creek Drive
Suite 110
Durham, NC 27703
United States
919 485 8080
https://www.novan.com

Sector(s): 
Industry: 
Full-time employees: 90

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Scott M. Plesha	CEO & Director	N/A	N/A	1965
Dr. Carri Geer Ph.D.	Senior VP & CTO	N/A	N/A	N/A
Mr. Sai Rangarao	Senior VP, Head of Sales & Marketing	N/A	N/A	N/A
Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Melvin Whitehead	Senior Vice President of Manufacturing Operations	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NVN Liquidation, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. NVN Liquidation, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was formerly known as Novan, Inc. and changed its name to NVN Liquidation, Inc. in October 2023. The company was incorporated in 2006 and is headquartered in Durham, North Carolina. On July 17, 2023, NVN Liquidation, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Corporate governance

NVN Liquidation, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.